CarrièresEspace presseCOVID-19
  1. Home
  2. Imagerie Médicale
  3. Angiographie (Arceaux fixes)
  4. Suite de traitement nexaris
  5. nexaris Angio-CT

nexaris Angio-CT At the nexus of treatment innovation

1/7
Interventional Radiology - nexaris Angio-CT- nexaris Angio-CT Hybrid Suite Picture
nexaris Angio-CT

At the nexus of treatment innovation

Interventional Radiology - nexaris Angio-CT- nexaris Angio-CT Hybrid Suite Picture
Interventional Radiology - nexaris Angio-CT- nexaris Angio-CT Instant Fusion Imaging Picture
Interventional Radiology - nexaris Angio-CT- nexaris Angio-CT Multi-Modality Technology Picture
1/7

The aging population and value-based reimbursement have raised demand for minimally invasive procedures that enhance both patient care and cost efficiency. This calls for innovation in IR.

The nexaris Angio-CT is the first hybrid suite with Instant Fusion that seamlessly integrates angio and CT2, 3 images. Even wireless ultrasound images can be displayed side-by-side on the large display. Angio, CT and ultrasound images are available at a single glance. Now it’s easier than ever to perform challenging, multi-modality procedures, streamline workflows and advance therapy outcomes with the peace of mind every pioneer needs.

  • Directly access angio and CT with stunning Instant Fusion4 and Quick Switching between modalities
  • Two teams share one CT in efficient multi-room configurations
  • Explore new procedures, devices and pathways with peace of mind
  • Assess treatment response and personalize treatment
1
This configuration is a customized solution and not commercially available in all countries. Due to regulatory reasons, future availability cannot be guaranteed.
2
The SOMATOM Edge Plus is pending 510(k) clearance, and is not yet commercially available in the U.S.
3
The feature to control the CT scanner with the Artis Cockpit is still under development and not commercially available yet. Its future availability cannot be guaranteed.
4
The new feature Instant Fusion is pending 510(k) clearance, and is not yet commercially available in the United States.